NCT05603104: Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
- State
- Stopped early
- Phase
- Phase 3
- People
- 1 taking part
- Started
- 27 Apr 2025
- Primary completion
- 24 Jun 2026
- Arms
- Schizophrenia EIPT: Switch to clozapine
- Results
- None posted
- 2 Nov 2022: Trial registered
- 27 Apr 2025: Trial started
- 24 Jun 2026: Trial terminated